⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
businesswire.com
MRK
Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight
globenewswire.com
BMY
PFE
AMGN
NVS
MRK
LLY
GILD
AZN
TAK
JNJ
ABBV
CRSP
MOD
ARVN
Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
prnewswire.com
REGN
MRK
ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight
prnewswire.com
PFE
MRK
LLY
AMGN
BMY
NVS
GILD
AZN
REGN
SNY
TEVA
IMUX
Cell Culture Market Analysis by Consumables, Vessels, Equipment, Application, and Competition - Global Forecast to 2031
globenewswire.com
TMO
DHR
MRK
IVZ
AGNC
BDX
BIO
The 5th Annual Connected Worker Manufacturing Summit Returns Bigger Than Ever with Its Largest Speaker Faculty, Expo Hall and Industry Audience to Date
prnewswire.com
CAT
PG
MRK
GM
XOM
HMC
ADM
MMM
KO
KHC
ROL
OC
HOG
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
GMAB
IMUX
INO
PDSB
AZN
GSK
MRK
BIIB
EXEL
REGN
CUE
IOBT
RAPT
PRE
Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy
businesswire.com
MRK
GILD
Virginia's Advanced Pharmaceutical Manufacturing Tech Hub Secures Federal Investment to Launch End-to-End Commercialization Project
prnewswire.com
AZN
LLY
MRK
Malignant Pleural Effusion Market to Register Incremental Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) | DelveInsight
globenewswire.com
CRSP
MRK
NVS
BMY
AZN
PFE
REGN